Xian Zhang

Hebei Yanda Lu Daopei Hospital - Department of Hematology

Langfang

China

SCHOLARLY PAPERS

1

DOWNLOADS

64

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

A Phase I Study of C-CAR088, a Novel Humanized Anti-BCMA CAR T Cell Therapy in Relapsed/Refractory Multiple Myelomaa

Number of pages: 35 Posted: 16 Mar 2022
Nanjing Medical University - Department of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Experimental Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Experimental Hematology, Hebei Yanda Lu Daopei Hospital - Department of Hematology, Hebei Yanda Lu Daopei Hospital - Department of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Hematology, Cellular Biomedicine Group Inc, Cellular Biomedicine Group Inc, Cellular Biomedicine Group Inc, Cellular Biomedicine Group Inc, Cellular Biomedicine Group Inc, Cellular Biomedicine Group Inc, University of Maryland - Department of Hematology/Oncology, Cellular Biomedicine Group Inc, Cellular Biomedicine Group Inc, Cellular Biomedicine Group Inc, Cellular Biomedicine Group Inc, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Hematology, Hebei Yanda Lu Daopei Hospital - Department of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Experimental Hematology and The First Affiliated Hospital of Nanjing Medical University - Department of Hematology
Downloads 64 (753,845)

Abstract:

Loading...

CAR T cell therapy, relapsed/refractory multiple myeloma